Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy

被引:0
|
作者
Marta Simó
Andreas A. Argyriou
Miquel Macià
Gerard Plans
Carles Majós
Noemi Vidal
Miguel Gil
Jordi Bruna
机构
[1] Hospital Universitari de Bellvitge-ICO Duran i Reynals and Institut de Diagnòstic per la Imatge,Neuro
[2] Saint Andrew’s General Hospital of Patras,Oncology Unit
[3] Centro de Investigación en Red en Bioingeniería,Department of Neurology
[4] Biomateriales y Nanomedicina (CIBER-BBN),undefined
来源
关键词
High-grade meningioma; Recurrent meningioma; Meningioma; Somatostatin; Octreotide;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:919 / 923
页数:4
相关论文
共 50 条
  • [1] Recurrent high-grade meningioma: a phase II trial with somatostatin analogue therapy
    Simo, Marta
    Argyriou, Andreas A.
    Macia, Miquel
    Plans, Gerard
    Majos, Carles
    Vidal, Noemi
    Gil, Miguel
    Bruna, Jordi
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) : 919 - 923
  • [2] RECURRENT HIGH-GRADE MENINGIOMA: PHASE II TRIAL WITH SOMATOSTATIN ANALOGUE THERAPY
    Simo, M.
    Macia, M.
    Plans, G.
    Majos, C.
    Gil, M.
    Izquierdo, C.
    Velasco, R.
    Bruna, J.
    [J]. NEURO-ONCOLOGY, 2012, 14 : 8 - 9
  • [3] Phase II trial of temozolomide in children with recurrent high-grade glioma
    Ruggiero, A.
    Cefalo, G.
    Garre, M. L.
    Massimino, M.
    Colosimo, C.
    Attina, G.
    Lazzareschi, I.
    Maurizi, P.
    Ridola, V.
    Mazzarella, G.
    Caldarelli, M.
    Di Rocco, C.
    Madon, E.
    Abate, M. E.
    Clerico, A.
    Sandri, A.
    Riccardi, R.
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2006, 77 (01) : 89 - 94
  • [4] A phase II trial of sunitinib in patients with recurrent high-grade glioma
    Chaskis, C.
    Sadones, J.
    Michotte, A.
    Dujardin, M.
    Everaert, H.
    Neyns, B.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] Phase II trial of temozolomide in children with recurrent high-grade glioma
    A. Ruggiero
    G. Cefalo
    M.L. Garré
    M. Massimino
    C. Colosimo
    G. Attinà
    I. Lazzareschi
    P. Maurizi
    V. Ridola
    G. Mazzarella
    M. Caldarelli
    C. Di Rocco
    E. Madon
    M.E. Abate
    A. Clerico
    A. Sandri
    R. Riccardi
    [J]. Journal of Neuro-Oncology, 2006, 77 : 89 - 94
  • [6] PHASE II TRIAL OF PEMBROLIZUMAB IN RECURRENT AND RESIDUAL HIGH-GRADE MENINGIOMAS
    Brastianos, Priscilla
    Kim, Albert
    Giobbie-Hurder, Anita
    Lee, Eudocia Quant
    Wang, Nancy
    Eichler, April
    Chukwueke, Ugonma
    Forst, Deborah
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Lou, Kevin
    Larson, Juliana
    Mora, Joana
    Nayyar, Naema
    Loeffler, Jay
    Oh, Kevin
    Shih, Helen
    Curry, William
    Cahill, Daniel
    Barker, Fred
    Gerstner, Elizabeth
    Santagata, Sandro
    [J]. NEURO-ONCOLOGY, 2021, 23 : 57 - 57
  • [7] A PHASE II CLINICAL TRIAL USING ACCELERATOR-BASED BNCT SYSTEM FOR REFRACTORY RECURRENT HIGH-GRADE MENINGIOMA
    Miyatake, Shin-Ichi
    Wanibuchi, Masahiko
    Kawabata, Shinji
    Ko, Naonori
    Ono, Koji
    [J]. NEURO-ONCOLOGY, 2020, 22 : 55 - 55
  • [8] Toward Radioguided Surgery with β- Decays: Uptake of a Somatostatin Analogue, DOTATOC, in Meningioma and High-Grade Glioma
    Collamati, Francesco
    Pepe, Alessandra
    Bellini, Fabio
    Bocci, Valerio
    Chiodi, Giacomo
    Cremonesi, Marta
    De Lucia, Erika
    Ferrari, Mahila E.
    Frallicciardi, Paola M.
    Grana, Chiara M.
    Marafini, Michela
    Mattei, Ilaria
    Morganti, Silvio
    Patera, Vincenzo
    Piersanti, Luca
    Recchia, Luigi
    Russomando, Andrea
    Sarti, Alessio
    Sciubba, Adalberto
    Senzacqua, Martina
    Camillocci, Elena Solfaroli
    Voena, Cecilia
    Pinci, Davide
    Faccini, Riccardo
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (01): : 3 - 8
  • [9] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 906 - 906
  • [10] A phase I/II trial of enzastaurin in patients with recurrent high-grade gliomas
    Kreisl, Teri N.
    Kotliarova, Svetlana
    Butman, John A.
    Albert, Paul S.
    Kim, Lyndon
    Musib, Luna
    Thornton, Donald
    Fine, Howard A.
    [J]. NEURO-ONCOLOGY, 2010, 12 (02) : 181 - 189